JPS5182294A - - Google Patents

Info

Publication number
JPS5182294A
JPS5182294A JP50147480A JP14748075A JPS5182294A JP S5182294 A JPS5182294 A JP S5182294A JP 50147480 A JP50147480 A JP 50147480A JP 14748075 A JP14748075 A JP 14748075A JP S5182294 A JPS5182294 A JP S5182294A
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP50147480A
Other languages
Japanese (ja)
Other versions
JPS6117837B2 (xx
Inventor
Mao Shin Kun
Dabitsudo Suriizaa Hooru
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bristol Myers Co
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of JPS5182294A publication Critical patent/JPS5182294A/ja
Publication of JPS6117837B2 publication Critical patent/JPS6117837B2/ja
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
JP50147480A 1974-12-13 1975-12-12 Expired JPS6117837B2 (xx)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US53266374A 1974-12-13 1974-12-13

Publications (2)

Publication Number Publication Date
JPS5182294A true JPS5182294A (xx) 1976-07-19
JPS6117837B2 JPS6117837B2 (xx) 1986-05-09

Family

ID=24122664

Family Applications (2)

Application Number Title Priority Date Filing Date
JP50147480A Expired JPS6117837B2 (xx) 1974-12-13 1975-12-12
JP60087656A Pending JPS615083A (ja) 1974-12-13 1985-04-25 抗生物質中間体の製法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP60087656A Pending JPS615083A (ja) 1974-12-13 1985-04-25 抗生物質中間体の製法

Country Status (21)

Country Link
JP (2) JPS6117837B2 (xx)
AT (1) AT343803B (xx)
AU (1) AU8688075A (xx)
BE (1) BE836428A (xx)
DD (1) DD123191A5 (xx)
DE (1) DE2556105A1 (xx)
DK (1) DK564175A (xx)
ES (1) ES443372A1 (xx)
FI (1) FI753518A (xx)
FR (1) FR2294179A1 (xx)
GR (1) GR58533B (xx)
IL (1) IL48644A0 (xx)
IN (1) IN143474B (xx)
LU (1) LU74003A1 (xx)
NL (1) NL7514391A (xx)
NO (1) NO754196L (xx)
NZ (1) NZ179268A (xx)
OA (1) OA05182A (xx)
RO (1) RO68147A (xx)
SE (1) SE7514034L (xx)
ZA (1) ZA757744B (xx)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3819621A (en) * 1970-12-30 1974-06-25 Fujisawa Pharmaceutical Co 3-substituted-thiomethyl-3-cephem-4-carboxylic acid derivatives
JPS4945879A (xx) * 1972-09-09 1974-05-01
KR780000197B1 (en) * 1972-12-26 1978-05-26 Bristol Myers Co Method for preparing antibacterial agent

Also Published As

Publication number Publication date
LU74003A1 (xx) 1976-11-11
GR58533B (en) 1977-10-31
NZ179268A (en) 1978-04-28
ATA938875A (de) 1977-10-15
FR2294179A1 (fr) 1976-07-09
FI753518A (xx) 1976-06-14
DK564175A (da) 1976-06-14
AU8688075A (en) 1977-06-02
DE2556105A1 (de) 1976-06-24
DD123191A5 (xx) 1976-12-05
ZA757744B (en) 1976-11-24
JPS615083A (ja) 1986-01-10
OA05182A (fr) 1981-01-31
RO68147A (ro) 1980-01-15
IL48644A0 (en) 1976-02-29
NO754196L (xx) 1976-06-15
AT343803B (de) 1978-06-26
ES443372A1 (es) 1977-12-01
IN143474B (xx) 1977-12-03
JPS6117837B2 (xx) 1986-05-09
SE7514034L (sv) 1976-06-14
BE836428A (fr) 1976-06-09
NL7514391A (nl) 1976-06-15

Similar Documents

Publication Publication Date Title
FR2281856B1 (xx)
FR2286008B1 (xx)
FR2262182A1 (xx)
FR2263255B1 (xx)
FR2264275A1 (xx)
FR2276704B1 (xx)
FR2262933B1 (xx)
FR2258256A1 (xx)
FR2265583A1 (xx)
FR2268060A1 (xx)
FI376474A (xx)
CS162590B1 (xx)
FI753518A (xx)
BG20931A1 (xx)
BG20720A1 (xx)
AU481580A (xx)
DD124740A5 (xx)
DD123582A5 (xx)
DD118995A5 (xx)
BG20693A1 (xx)
BG20939A1 (xx)
BG20665A1 (xx)
BG20903A1 (xx)
BG20899A1 (xx)
BG20850A1 (xx)